Cresco Labs (CRLBF) Gains from Sales and Divestitures (2022 - 2023)
Cresco Labs (CRLBF) reported Gains from Sales and Divestitures of $1.2 million for Q2 2023, down 39.57% on a YoY basis from $2.0 million in Q2 2022, and up 1739.39% quarter-over-quarter from $66000.0 in Q1 2023.
Cresco Labs (CRLBF) Gains from Sales and Divestitures (2022 - 2023) Analysis & Trends
Cresco Labs has reported Gains from Sales and Divestitures for 2 years, with the latest figure at $1.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 66,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Sep 30, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | 2.01 Mn |